-
Mayo Clinic president and CEO participates in the Coronavirus Task Force meeting
Share this:
Gianrico Farrugia, M.D., president and CEO of Mayo Clinic, attended a meeting on Wednesday, March 11, convened by the White House Coronavirus Task Force.
The task force is led by Vice President Mike Pence and the meeting included Seema Verma, administrator of the Centers for Medicare and Medicaid Services and other hospital sector leaders. The focus of the task force is on the ongoing response to the outbreak of COVID-19, and to ensure seamless collaboration between the federal government and health care providers.
President and CEO of
Mayo Clinic
At the meeting, Dr. Farrugia emphasized Mayo Clinic's preparedness and expertise in responding to COVID-19 and expressed the organization's support for local, state and federal officials who are leading the nation's response to the pandemic. "I was pleased to have the opportunity to meet with peers, share best practices and highlight Mayo Clinic’s commitment to ensuring patients have access to testing and treatment for COVID-19," Dr. Farrugia says.
"As a trusted voice on health care issues, we are stepping up to address the public's concerns, ensure health care staff are adequately protected, and develop solutions to COVID-19's unique challenges. Given the potential impact of the virus on communities small and large, we must come together seamlessly to deploy our resources. Today's discussion was a step in the right direction, and we look forward to continued collaboration.”
Media contact:
- Duska Anastasijevic, Mayo Clinic Public Affairs, newsbureau@mayo.edu
Share this:
Related articles
Influenza, respiratory syncytial virus (RSV), and COVID-19 are all part of the seasonal respiratory virus lineup. According to the Centers for Disease Control and Prevention ...
At-home COVID-19 tests allow you to collect your sample and detect active COVID-19 infections. But what if you have at-home COVID-19 tests nearing expiration or expired ...
Ahead of the fall respiratory virus season, the Food and Drug Administration has approved two updated COVID-19 vaccines. The new messenger RNA, or mRNA, vaccines ...